Article Abstract:
The government has decided to delicence and dereserve 5 bulk drugs which were previously reserved for production exclusively by the public sector. The drugs likely to be decontrolled are tetracycline, oxytetracycline, Vitamin B1, Vitamin B2 and folic acid. Decontrolling these drugs will benefit consumers as it will lead to more competition and, as a result, bring down their prices. The imports of the drugs will also decline. The only public sector company producing these drugs, Indian Drugs and Pharmaceuticals Ltd, is on the verge of closure and has not been able to meet the requirements of consumers. (khr)
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The computer industry is likely to be adversely affected as the import duty on Pentium II processor and Celeron chips has been raised by 36 percent. This may increase the cost of personal computers. The companies likely to be affected include Intel and Cyrix. The Department of Electronics has classified the Pentium II processor and Celeron chips under Printed Circuit Boards instead of Integrated Circuits. Intel is likely to incur an additional expenditure of Rs100 crore due to the increase in import duty. (nr)
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Abbott Laboratories India Ltd, a subsidiary of Abbott Inc of the US, has been given permission by the government to classify its manufacturing facility at Ankleshwar in Gujarat as a small scale unit. The unit has qualified for the classification as investments made in plant and equipment in 1984 were below Rs3 crore. The classification exempts the unit from price control. The unit produces anaesthetic pentothal sodium. (khr)
Comment:
Has been given permission by govt to classify its manufacturing facility at Ankleshwar in Gujarat as small scale unit
User Contributions:
Comment about this article or add new information about this topic: